(Q46216910)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052974%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Enumeration of blood dendritic cells in patients with multiple myeloma at presentation and through therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052974%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052974%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Ian M Franklin

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052974%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

John D M Campbell

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052974%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

1 December 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052974%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052974%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052974%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052974%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

2272-2283

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052974%20AND%20SRC:MED&resulttype=core&format=json

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464729

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464729

Chronic but not acute graft-versus-host disease improves outcome in multiple myeloma patients after non-myeloablative allogeneic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464729

Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464729

Immunotherapy of multiple myeloma: the start of a long and tortuous journey

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464729

Immune regulation in multiple myeloma: the host-tumour conflict

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464729

Either interleukin-12 or interferon-gamma can correct the dendritic cell defect induced by transforming growth factor beta in patients with myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464729

Breast cancer-associated antigen, DF3/MUC1, induces apoptosis of activated human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464729

Bone marrow plasmacytoid dendritic cells can differentiate into myeloid dendritic cells upon virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464729

Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464729

BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464729

Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464729

Plasmacytoid dendritic cells: linking innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464729

Lymphocyte subset reference ranges in adult caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464729

Severe deficiency of B lymphocytes in peripheral blood from multiple myeloma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464729

In vitro dendritic cell generation and lymphocyte subsets in myeloma patients: influence of thalidomide and high-dose chemotherapy treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464729

Circulating clonotypic B cells in the biology of multiple myeloma: speculations on the origin of myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464729

Differential dysfunction in dendritic cell subsets during chronic HCV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464729

Enhancement of cytokine production and AP-1 transcriptional activity in T cells by thalidomide-related immunomodulatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464729

Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464729

Dendritic cell maturation stage determines susceptibility to the proteasome inhibitor bortezomib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464729

Bortezomib significantly impairs the immunostimulatory capacity of human myeloid blood dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464729

Bortezomib disrupts tumour-dendritic cell interactions in myeloma and lymphoma: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464729

Histone deacetylase activities are required for innate immune cell control of Th1 but not Th2 effector cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464729

10.1080/10428190802464729

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19052974%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference